A fair point Money but this looks like the year of the stem cell.
I hold MSB, CYP, OCC and RGS and if one does particularly well, the others will be sucked up in the slipstream and also go higher.
My short term bet is CYP and long term MSB.
- Forums
- Commodities
- Biotech 2017
Biotech 2017, page-21
- There are more pages in this discussion • 55 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Featured News
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
Previous Video
Next Video
SPONSORED BY The Market Online